Published in Gene Therapy Weekly, November 24th, 1997
Antibiotics and a substance that attacks the damage caused by arthritis at the molecular level also could offer novel ways to attack the painful and crippling disease, scientists told a meeting of the American College of Rheumatology.
Some of the treatments are being tested in people, while others are years away from development. But all show that a greater understanding of the processes that underlie both rheumatic and osteoarthritis can transform how they are treated.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.